INVANZ

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug INVANZ contains one active pharmaceutical ingredient (API):

1 Ertapenem UNII 2T90KE67L0 - ERTAPENEM SODIUM

Ertapenem inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). In Escherichia coli, affinity is strongest to PBPs 2 and 3. Read about Ertapenem

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
INVANZ Powder for concentrate for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DH03	Ertapenem	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DH Carbapenems
Discover more medicines within J01DH03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525501301159216
Country: CA	Health Products and Food Branch	Identifier(s): 02247437
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 24.529-06-02
Country: EE	Ravimiamet	Identifier(s): 1111431, 1131062
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 02216001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 010234
Country: FR	Base de données publique des médicaments	Identifier(s): 65077051
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 47799
Country: HK	Department of Health Drug Office	Identifier(s): 51101
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7749
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1011780, 1028456
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 161M2001
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 63525
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10048
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100113215
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64643001, W64643002
Country: SG	Health Sciences Authority	Identifier(s): 11855P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 7013121H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699636790205
Country: US	FDA, National Drug Code	Identifier(s): 0006-3843
Country: ZA	Health Products Regulatory Authority	Identifier(s): 37/20.1.1/0424